Up 810% in a year, the Mesoblast share price is surging again on Monday. Here’s why
Image source: Getty Images
The Mesoblast Ltd (ASX: MSB) share price is racing higher today.
Again.
Shares in the (as of now) S&P/ASX 300 Index (ASX: XKO) clinical-stage biotechnology company closed on Friday trading for $2.52. In earlier trade, shares were up 8.3% at $2.73 each. That saw the stock up an eye-popping 810% since this time last year.
Or enough to turn an $8,000 investment into $72,800. In just 12 months.
After some likely profit-taking, the Mesoblast share price is currently trading at $2.65, up 5.2%.
Here’s what’s grabbing ASX 200 investor interest today.
Mesoblast share price benefits from its own success
The ASX 200 biotech stock appears to be garnering additional tailwinds today generated by its own lengthy run…
